The 1st International Electronic Conference on Biomolecules: Natural and Bio-Inspired Therapeutics for Human Diseases 2020
DOI: 10.3390/iecbm2020-08586
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of TNF-Alpha Using Plant-Derived Small Molecules for Treatment of Inflammation-Mediated Diseases

Abstract: Inhibition of TNF-α has become a feasible target for alleviating inflammation-mediated diseases. Currently, techniques developed, such as anti-TNF antibody therapies, prove not to be nearly as beneficial enough to effectively treat inflammation-mediated syndromes because of the increased risk for severe infections and malignancies. Our study has undertaken the attempt of identifying small molecules to inhibit TNF-α. This study manually selected 37 plant-derived compounds based on IC50 value from various litera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 84 publications
(78 reference statements)
0
3
0
Order By: Relevance
“…Tyr-59, Tyr-151, and Tyr-119 are active amino acids that play a crucial role in TNF-α function. By binding to this amino acid, the inhibitor can significantly impair its function (Parves et al, 2021). In addition to the active residue of tyrosine, the TNF-α binding site is composed of Leu-57, Ser-60, Gln-61, Leu-120, Gly-121, and Gly-122, so that binding to these amino acids can cause inhibition of their biological activity (He et al, 2005).…”
Section: Resultsmentioning
confidence: 99%
“…Tyr-59, Tyr-151, and Tyr-119 are active amino acids that play a crucial role in TNF-α function. By binding to this amino acid, the inhibitor can significantly impair its function (Parves et al, 2021). In addition to the active residue of tyrosine, the TNF-α binding site is composed of Leu-57, Ser-60, Gln-61, Leu-120, Gly-121, and Gly-122, so that binding to these amino acids can cause inhibition of their biological activity (He et al, 2005).…”
Section: Resultsmentioning
confidence: 99%
“…The primary objective of this study is to explore the roles of specific phenolic acid phytocompounds in healing hyperinflammation through their potential interactions with target proteins. To achieve a comprehensive understanding of their therapeutic mechanisms, a multifaceted approach was employed, integrating network pharmacology, docking studies, and molecular dynamics simulations. …”
Section: Introductionmentioning
confidence: 99%
“…To achieve a comprehensive understanding of their therapeutic mechanisms, a multifaceted approach was employed, integrating network pharmacology, docking studies, and molecular dynamics simulations. 18 20 …”
Section: Introductionmentioning
confidence: 99%